Literature DB >> 14618419

A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes.

Borut Peterlin1, Mojca Globočnik Petrovič2, Jana Makuc1, Marko Hawlina2, Daniel Petrovič3.   

Abstract

Iron metabolism might be involved in the pathogenesis of type 2 diabetes and in the pathogenesis of diabetic retinopathy. C282Y and H63D mutations in the hemochromatosis (HFE) gene are associated with increased serum iron levels and consequently with hereditary hemochromatosis. In the present study, we searched for a relationship between C282Y and H63D gene mutations and the development of proliferative diabetic retinopathy in Caucasians with type 2 diabetes. For this purpose, 90 subjects with type 2 diabetes with proliferative diabetic retinopathy (PDR) were compared to 133 diabetic subjects without PDR. There was a significantly higher frequency of the C282Y heterozygotes in patients with PDR compared to subjects without it (OR=3.0, 95% CI=1.2-8.0; p=0.02), whereas no association was demonstrated between PDR and H63D genotypes (OR=1.1, 95% CI=0.6-2.2; p=0.7). Logistic regression analysis revealed that the C282Y mutation was a significant independent risk factor for the development of PDR (OR=6.1, 95% CI=1.2-30.5; p=0.027). These data suggest that heterozygosity for C282Y might be a novel risk factor for PDR in Caucasians with type 2 diabetes.

Entities:  

Mesh:

Year:  2003        PMID: 14618419     DOI: 10.1007/s10038-003-0094-3

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  22 in total

1.  Evaluation of the iron status of a population.

Authors:  J D Cook; C A Finch; N J Smith
Journal:  Blood       Date:  1976-09       Impact factor: 22.113

2.  Proliferative retinopathy in a patient with diabetes mellitus and idiopathic haemochromatosis.

Authors:  C H Walsh; J M Malins
Journal:  Br Med J       Date:  1978-07-01

3.  Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study.

Authors:  M Porta; A K Sjoelie; N Chaturvedi; L Stevens; R Rottiers; M Veglio; J H Fuller
Journal:  Diabetologia       Date:  2001-12       Impact factor: 10.122

4.  The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression.

Authors:  J N Feder; Z Tsuchihashi; A Irrinki; V K Lee; F A Mapa; E Morikang; C E Prass; S M Starnes; R K Wolff; S Parkkila; W S Sly; R C Schatzman
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

5.  Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy.

Authors:  D K Moczulski; W Grzeszczak; B Gawlik
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

6.  Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts.

Authors:  J G Parkes; Y Liu; J B Sirna; D M Templeton
Journal:  J Mol Cell Cardiol       Date:  2000-02       Impact factor: 5.000

7.  Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract.

Authors:  S Parkkila; A Waheed; R S Britton; J N Feder; Z Tsuchihashi; R C Schatzman; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 8.  Cross-talk between iron metabolism and diabetes.

Authors:  José Manuel Fernández-Real; Abel López-Bermejo; Wifredo Ricart
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

9.  Lysosomal iron accumulation in diabetic nephropathy.

Authors:  B J Nankivell; Y C Tay; R A Boadle; D C Harris
Journal:  Ren Fail       Date:  1994       Impact factor: 2.606

10.  Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study.

Authors:  K Dahl-Jørgensen; O Brinchmann-Hansen; K F Hanssen; L Sandvik; O Aagenaes
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-16
View more
  9 in total

Review 1.  Diabetes and hemochromatosis.

Authors:  T Creighton Mitchell; Donald A McClain
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

2.  Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy.

Authors:  Suganthalakshmi Balasubbu; Periasamy Sundaresan; Anand Rajendran; Kim Ramasamy; Gowthaman Govindarajan; Namperumalsamy Perumalsamy; J Fielding Hejtmancik
Journal:  BMC Med Genet       Date:  2010-11-10       Impact factor: 2.103

3.  Poor lysosomal membrane integrity in proximal tubule cells of haptoglobin 2-2 genotype mice with diabetes mellitus.

Authors:  Rabea Asleh; Farid M Nakhoul; Rachel Miller-Lotan; Hoda Awad; Dan Farbstein; Nina S Levy; Nakhoul Nakhoul; Theodore C Iancu; Irena Manov; Michael Laue; Maret G Traber; Katie M Lebold; Andrew P Levy
Journal:  Free Radic Biol Med       Date:  2012-06-27       Impact factor: 7.376

4.  Iron Overload Accelerates the Progression of Diabetic Retinopathy in Association with Increased Retinal Renin Expression.

Authors:  Kapil Chaudhary; Wanwisa Promsote; Sudha Ananth; Rajalakshmi Veeranan-Karmegam; Amany Tawfik; Pachiappan Arjunan; Pamela Martin; Sylvia B Smith; Muthusamy Thangaraju; Oleg Kisselev; Vadivel Ganapathy; Jaya P Gnana-Prakasam
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

5.  Association between Iron Intake and Diabetic Peripheral Neuropathy in Type 2 Diabetes: Significance of Iron Intake and the Ratio between Iron Intake and Polyunsaturated Fatty Acids Intake.

Authors:  Kyuho Kim; YoonJu Song; Tae Jung Oh; Sung Hee Choi; Hak Chul Jang
Journal:  Nutrients       Date:  2020-11-01       Impact factor: 5.717

6.  Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study.

Authors:  Timothy M E Davis; John Beilby; Wendy A Davis; John K Olynyk; Gary P Jeffrey; Enrico Rossi; Conchita Boyder; David G Bruce
Journal:  Diabetes Care       Date:  2008-06-19       Impact factor: 19.112

7.  Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy.

Authors:  Mojca Globocnik Petrovic; Peter Korosec; Mitja Kosnik; Josko Osredkar; Marko Hawlina; Borut Peterlin; Daniel Petrovic
Journal:  Mol Vis       Date:  2008-07-30       Impact factor: 2.367

Review 8.  Candidate genes for proliferative diabetic retinopathy.

Authors:  Daniel Petrovič
Journal:  Biomed Res Int       Date:  2013-08-27       Impact factor: 3.411

9.  Acute Free-Iron Exposure Does Not Explain the Impaired Haemorheology Associated with Haemochromatosis.

Authors:  Antony P McNamee; Surendran Sabapathy; Indu Singh; Jarod Horobin; Janelle Guerrero; Michael J Simmonds
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.